Allele-Specific Down-Regulation of RPTOR Expression Induced by Retinoids Contributes to Climate Adaptations by Sun, Chang et al.
Allele-Specific Down-Regulation of RPTOR Expression
Induced by Retinoids Contributes to Climate Adaptations
Chang Sun, Catherine Southard, David B. Witonsky, Ralf Kittler
¤, Anna Di Rienzo*
Department of Human Genetics, University of Chicago, Chicago, Illinois, United States of America
Abstract
The mechanistic target of rapamycin (MTOR) pathway regulates cell growth, energy homeostasis, apoptosis, and immune
response. The regulatory associated protein of MTOR encoded by the RPTOR gene is a key component of this pathway. A
previous survey of candidate genes found that RPTOR contains multiple SNPs with strong correlations between allele
frequencies and climate variables, consistent with the action of selective pressures that vary across environments. Using
data from a recent genome scan for selection signals, we honed in on a SNP (rs11868112) 26 kb upstream to the
transcription start site of RPTOR that exhibits the strongest association with temperature variables. Transcription factor motif
scanning and mining of recently mapped transcription factor binding sites identified a binding site for POU class 2
homeobox 1 (POU2F1) spanning the SNP and an adjacent retinoid acid receptor (RAR) binding site. Using expression
quantification, chromatin immunoprecipitation (ChIP), and reporter gene assays, we demonstrate that POU2F1 and RARA
do bind upstream of the RPTOR gene to regulate its expression in response to retinoids; this regulation is affected by the
allele status at rs11868112 with the derived allele resulting in lower expression levels. We propose a model in which the
derived allele influences thermogenesis or immune response by altering MTOR pathway activity and thereby increasing
fitness in colder climates. Our results show that signatures of genetic adaptations can identify variants with functional
effects, consistent with the idea that selection signals may be used for SNP annotation.
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Introduction
A major goal of human genetics is to identify functional
genomic regions, especially those containing variants that
influence common disease susceptibility or disease-related pheno-
types. However, due to the complexity of the genome, it is not easy
to distinguish functional from non-functional regions, especially for
regulatory elements, which can lie far from the target gene.
Because adaptive variation must necessarily have functional, in
addition to fitness effects, signals of positive natural selection have
been proposed as an informative approach to the functional
annotation of the genome. Many genome-wide selection scans
have been performed to date based on different approaches (as
reviewed by references [1–5]). These studies have generated a
large number of signals, most of which await validation through
functional or phenotypic analyses.
One approach to the detection of local adaptations searches for
correlations between allele frequencies and environmental vari-
ables, e.g. latitude or temperature; this approach assumes that the
intensity of selection varies across environments and that the
variables correlated with allele frequencies are good proxies for the
true selective pressure (e.g. temperature is a proxy for cold or heat
stress). This approach may be particularly informative for human
populations who originated in Sub-Saharan Africa and migrated
out of Africa 60–100k years ago to occupy most of the earth
landmass [6,7]. During this dispersal, human populations have
been exposed to extremely diverse environments, which differ in
terms of climate, including temperature, day length, UV radiation,
pathogen diversity and other factors. These aspects of human
environments have important effects on physiological and
developmental processes and, therefore, exerted strong selective
pressures on the human genome [8]. Consistent with the action of
spatially-varying selective pressures, human skin pigmentation [9],
body mass [10], basal metabolic rates (BMR) [11], and cranial
form [12] vary across human populations and are associated with
climate variables. It was recently shown that polymorphisms in
candidate genes for metabolic disorders [13], salt homeostasis
[14,15], response to stress [16,17], and circadian signaling [18],
are strongly correlated with climate variables, thus providing a
possible genetic mechanism for the observed distribution of human
phenotypes across populations.
One of these studies identified the RPTOR gene as a target of
spatially-varying selective pressures because many variants within
the gene exhibited particularly strong correlations between allele
frequency and latitude [13]. The RPTOR gene codes for a protein
involved in the target of rapamycin (MTOR) pathway, which in
turn is important in cell growth, proliferation, apoptosis [19], and
immune response [20]. Two multiprotein complexes, MTORC1
and MTORC2, constitute the core of this pathway [19];
MTORC1 is the target of and sensitive to rapamycin, an
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complex is not [19]. Under the regulation of nutrient, energy,
and stress, MTORC1 can transfer the proliferation signal to the
downstream proteins mainly by phosphorylating two substrates,
ribosomal protein S6 kinase, 70kDa, polypeptide 1 (RPS6KB1)
and eukaryotic translation initiation factor 4E binding protein 1
(EIF4EBP1) [19]. The regulatory associated protein of MTOR
(RPTOR) is a crucial component of the MTORC1 [21], which
works both as a scaffold and a regulatory protein [21,22]. In
particular, RPTOR can bind to TOR signaling (TOS) domain of
EIF4EBP1 and RPS6KB1 [23–25] and to the HEAT repeat
domain of MTOR [21], thus making the phosphorylation reaction
possible. Therefore, in absence of RPTOR, the kinase activity of
MTOR is mainly reduced or inhibited [21]. Given the function of
this pathway and its regulation in response to environmental
stimuli, it is plausible that the RPTOR variants correlated with
latitude, or one in strong linkage disequilibrium (LD) with these
SNPs, conferred adaptations to selective pressures that vary across
environments. However, the mechanism through which this
variation affects the function of the RPTOR gene remains
unknown.
In the present study, we used population genetics analyses and
in vitro functional assays to localize the most likely target of
selection and to propose a mechanism underlying its effect on
RPTOR gene function. More specifically, we used the results of a
genome-wide selection scan to identify the variant with the
strongest evidence as a target of climate adaptations (Hancock and
Di Rienzo, personal communication). This SNP lies within a
predicted POU class 2 homeobox 1 (POU2F1) binding site and
near a retinoid acid receptor (RAR) binding site identified by
Chromatin immunoprecipitation (ChIP)-chip [26]. Given that
POU2F1 and RAR are known to cooperate in the regulation of
gene expression, we hypothesized that this SNP is located within
an enhancer that regulates RPTOR expression in response to
retinoid acid (RA). Consistent with this prediction, we observed a
significant increase of RPTOR expression in both MCF-7 and
HepG2 cell lines after treatment with RA. We further showed that
both POU2F1 and RAR bind to the region spanning the SNP of
interest in both cell lines. Finally, we determined that the two
alleles at this SNP influence RA-mediated transcriptional response
by means of reporter gene assays using enhancer constructs
containing, respectively, the ancestral and the derived allele. Based
on these results, we propose that the SNP that is strongly
correlated with climate variables affects fitness by influencing
RPTOR gene expression.
Results
Refining the location of the selection target
To refine the location of the polymorphism targeted by climate-
related selective pressures, we mined the results of a recent
genome-wide scan for signals of allele frequency correlation with
climate variables (Hancock and Di Rienzo, personal communica-
tion). Allele frequencies for a total of 156 SNPs were obtained in
the genomic region spanning the RPTOR gene and 100 kb
upstream and downstream of the gene (See Table S1 for detailed
information). The evidence for the action of selective pressures
related to climate was assessed by means of a Bayesian method
that yields a Bayes factor (BF), which is a measure of the support
for a model in which a SNP allele frequency distribution is linearly
dependent on a climate variable in addition to population
structure, relative to a model in which the allele frequency
distribution is dependent on population structure alone [27]. A
transformed rank statistic (sometime referred to as an ‘empirical p-
value’) was also calculated to determine whether the BF value of a
SNP of interest is unusual relative to those of other SNPs matched
by allele frequency; as with formal p-values, a low rank indicates
strong evidence for a correlation (i.e. a large BF) [27]. We
examined the following climate variables: mean, minimum and
maximum temperature, precipitation rate, relative humidity and
solar radiation; for all climate variables we considered the value in
the winter and summer, respectively. Among the 156 SNPs tested,
56 had a rank lower that 5% for at least one climate variable. One
SNP, rs11868112, had particularly large BFs with winter
temperatures (rank statistic=0.0082, 0.0064, and 0.0039 for
minimum, mean and maximum winter temperature, respectively.
See Figure 1 and Figure 2, Table S2 and Table S3 for detail.).
Therefore, this SNP, or one in strong LD with it, is a candidate
target of selective pressures related to climate.
To determine whether an unknown coding SNP could account
for the above correlations with climate variables, we re-sequenced
the RPTOR cDNA from a small, but diverse group of HapMap
lymphoblastoid cell lines. As shown in Figure S1, 38 SNPs were
identified; 5 and 17 of them were located in 59 and 39 untranslated
regions, respectively. No non-synonymous SNP was identified.
Moreover, all of them showed a relatively low LD with rs11868112
(r
2,0.62, 0.34, and 0.69 in YRI, CEU, and ASN populations,
respectively). These results indicate that the selection signal is not
due to a non-synonymous SNP and suggest that the selection target
is not likely tobe withinthecoding region.Because the true target of
selection could be a regulatory SNP, we re-sequenced also 22.6kb of
conserved non-coding elements near the RPTOR gene, the RPTOR
promoter, and a 2.6 kb region spanning rs11868112. As shown in
Figure S2, 11, 16, and 135 SNPs were found in the intergenic,
promoter, and intron regions, respectively; polymorphism levels
were within the range of genome-wide variation (see Table S4)
[28,29]. Moreover, none of the additional 161 SNPs discovered in
this survey showed strong LD with rs11868112 (r
2,0.23, 0.48, and
0.54 in YRI, CEU, and ASN populations, respectively, result not
shown). Therefore, our targeted re-sequencing survey did not
identify SNPs with likely functional effects and that could drive the
signal seen at rs11868112.
Author Summary
Climate has exerted strong selective pressures in human
populations during their dispersal, and signatures of these
adaptations are still detectable in the geographic distri-
bution of polymorphisms. RPTOR is a key component of
the mechanistic target of rapamycin pathway, which
regulates cell growth, metabolism, and immune response;
and its deregulation is associated with human diseases,
including cancer and diabetes. Previous studies showed
that variation in RPTOR carry strong signatures of
adaptations to different climates. Here, we used evolu-
tionary genetics approaches coupled with transcription
factor motif data mining to refine the location of the
selection target. We then used functional assays to show
that the selected polymorphism resides in a sequence
element that regulates gene expression levels in response
to retinoids. The derived allele at this SNP, which results in
lower expression levels, increases in frequency with
decreasing temperatures, consistent with the notion that
it confers a selective advantage in colder climates possibly
through its effects on energy metabolism or immune
response. These results suggest a novel regulatory role for
retinoids in MTOR signaling. Moreover, they support the
proposal that evolutionary approaches can be informative
for SNP functional annotation.
Natural Selection on the Human RPTOR Gene
PLoS Genetics | www.plosgenetics.org 2 October 2010 | Volume 6 | Issue 10 | e1001178Figure 1. Association between 156 RPTOR SNPs and winter temperature variables. The nucleotide position of each SNP (based on build 36)
is shown on the horizontal axis and the log10 BF is shown on the vertical axis. The RefSeq genes in this region are displayed at the top.
doi:10.1371/journal.pgen.1001178.g001
Figure 2. Allele frequency for rs11868112 (ancestral and derived alleles are shown in white and black, respectively) in HGDP
populations mapped onto a GIS map of Winter maximum temperature.
doi:10.1371/journal.pgen.1001178.g002
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based on the allele frequency spectrum, but no significant
departure was detected (Table S4). This may be due to the fact
that these tests are known to have inadequate power under a range
of selection scenarios, including models in which selection acted on
an allele occurring at appreciable frequencies prior to the onset of
selection [30–32].
SNP rs11868112 lies 26.2 kb 59 to the RPTOR gene, which is
ubiquitously expressed and is a strong biological candidate for
adaptations to different local environments, and 41.3 kb 39 to the
NPTX1 gene, which is transcribed in the opposite orientation
relative to RPTOR. NPTX1 codes for neuronal pentraxin 1 that is
expressed only in the central neurons of the nervous system where
it plays a role in synaptic plasticity [33]; given its function, the
NPTX1 gene is a less likely target of adaptations to different
climates. We hypothesized that the SNP rs11868112 is located
within a long-distance regulatory element and that this SNP
influences the activity of this regulatory element. This hypothesis
was bolstered by the fact that this SNP lies less than 1 kb away
from a retinoic acid receptor a (RARA) binding site detected by
ChIP-chip in the breast cancer cell line MCF-7 [26]. We also
found that rs11868112 resides within a canonical POU2F1
binding site, as predicted by the Match program in the
TRANSFAC database (http://www.gene-regulation.com). Since
POU2F1 is known to cooperate with RARA to regulate gene
expression [34], we hypothesize that RPTOR gene expression is
regulated by retinoids via activation of the RARA and that
rs11868112 modulates the activation of RPTOR expression by
modifying POU2F1 binding affinity to the DNA.
Regulation of RPTOR expression by retinoids
To investigate the effects of retinoids on RPTOR expression, we
treated HepG2 and MCF-7 cell lines with the selective RARA
agonist AM580, which has greater specificity for RARA compared
to all-trans RA [35], for different time periods (2–48 hrs) and
measured RPTOR mRNA levels by quantitative real time PCR.
The MCF-7 cell line was included because the RARA binding site
was originally identified in these cells while the human
hepatocellular carcinoma cell line HepG2 was included because
the liver plays a prominent role in biological processes relevant to
energy metabolism (e.g. carbohydrate and lipid metabolism). The
genotype of rs11868112 is TT and CT for MCF-7 and HepG2,
respectively. As shown in Figure 3A, RPTOR expression in HepG2
varied substantially across time points for vehicle (DMSO) control
treatment. A 33.7% higher expression level was observed for
12 hrs treatment with AM580 versus DMSO (P=0.01). For all
other time points, no significant difference (P.0.05) was observed
for AM580 and DMSO treatment. In MCF-7 cells, where we
observed considerably less variation in RPTOR expression for
DMSO treatment across time points, we found a significant
increase of RPTOR mRNA levels upon AM580 treatment at 12, 24
and 48 hrs (38.1%, 50.8%, and 62.5% higher expression, and
P,0.001, P=0.01, and P=0.02 respectively, Figure 3B). A
relatively late (12 hrs or more) transcriptional response to retinoids
has been observed for many other target genes of RARA
[34,36,37]; however, it remains unclear whether the RPTOR gene
is a direct or indirect target. These findings suggest that RPTOR
expression may be regulated by RARA binding to the genomic
region adjacent to SNP rs11868112.
Binding of RARA and POU2F1 to the rs11868112 region
To investigate the role of SNP rs11868112 in the regulation of
RPTOR expression, we performed ChIP assays followed by
quantitative PCR to determine whether RARA and/or POU2F1
bind the DNA near the SNP. First, we treated HepG2 and MCF-7
cells with AM580 and DSMO and performed a ChIP with
antibodies against RARA followed by real time PCR quantifica-
tion of the region spanning the RARA binding site detected by
ChIP-chip [26]. We found a significant enrichment (P,0.02) of
the putative RARA binding region for the chromatin immuno-
precipitated DNA with the RARA antibody (Figure 4A and 4B),
which confirms RARA binding to the region near rs11868112.
This enrichment was observed in both DMSO and AM580
treated cells (Figure 4A and 4B), which is consistent with the model
for the genomic actions of retinoic acid receptors [38].
To investigate whether POU2F1 binds to the region encom-
passing rs11868112 (in a canonical POU2F1 motif) and to study
the retinoic acid dependency of POU2F1 recruitment, we
performed ChIP with antibodies against POU2F1 in the same
cell lines. Upon AM580 treatment, we observed a significant
enrichment (P,0.01) of the putative POU2F1 binding region in
the chromatin immunoprecipitated with the POU2F1 antibody in
Figure 3. Effect of retinoids on RPTOR expression in HepG2 (A) and MCF-7 (B) cell lines at different treatment times. Each bar indicates
the average of three independent biological replicates and the error bar denotes standard deviation. * P,0.05; *** P,0.001.
doi:10.1371/journal.pgen.1001178.g003
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POU2F1 binding to the genomic region encompassing
rs11868112. For vehicle treatment we observed no significant
POU2F1 binding in HepG2 cells (P.0.2, Figure 5A), but a
significant enrichment in MCF-7 cells (Figure 5B), which suggests
that POU2F1 binding to this specific genomic locus may not
require liganded RARA dependent on the specific cell lineage.
Overall, our findings indicate that RARA and POU2F1 bind to
the region adjacent to and encompassing rs11868112, respectively,
suggesting that this region acts as a cis-regulatory module with
POU2F1 and RARA-binding elements.
Enhancer activity of the rs11868112 alleles
To test whether POU2F1 and RARA binding to this module
elicits cis-regulatory effects dependent on the allele status of
rs11868112, we performed luciferase reporter gene assays with the
cloned regions of the ancestral and the derived allele. In HepG2
cells, the reporter gene construct containing the ancestral allele (C)
exhibited a 19.2% higher luciferase activity than the construct for
the derived allele (T) allele (P=0.011) 12 hrs after AM580
treatment (Figure 6A). Before and after this time point, no
significant difference was observed between the reporter gene
constructs for the C and T alleles (P.0.09). This observation is
consistent with the maximal RA-dependent induction of RPTOR
expression at 12 hrs after AM580 treatment. Similar results were
obtained with the MCF-7 cell line, where the reporter construct
for the ancestral allele showed a 24.1% higher luciferase activity
than those for the derived allele at 12 hrs after AM580 treatment
(P=0.0053, Figure 6B). These findings suggest that the region
26.2 kb upstream of RPTOR acts as an RA-dependent enhancer in
human cells and that the activity of this enhancer depends on the
allele status within the POU2F1 binding site at rs11868112.
Discussion
In this study, we combined population genetics, bioinformatics,
and experimental approaches to identify a cis-regulatory element
Figure 4. Enrichment of the region nearby rs11868112 in Anti-RAR ChIPed DNA relative to rabbit IgG ChIPed after AM580 and
DMSO treatment. In HepG2 (A) and MCF-7 (B). Each bar indicates the average of three real time PCR technical replicates normalized by the input
DNA and the error bar denotes standard deviation.
doi:10.1371/journal.pgen.1001178.g004
Figure 5. Enrichment of the region spanning rs11868112 in Anti-POU2F1 ChIPed DNA relative to rabbit IgG ChIPed after AM580
and DMSO treatment. In HepG2 (A) and MCF-7 (B). Each bar indicates the average of three real time PCR technical replicates normalized by the
input DNA and the error bar denotes standard deviation.
doi:10.1371/journal.pgen.1001178.g005
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selection identified in a genome-wide study. The allele frequencies
at this SNP are strongly correlated with latitude and winter
temperature variables. A re-sequencing survey did not identify
additional SNPs that are in strong LD with rs11868112 and that are
likely tohave functional effects.Because SNPrs11868112 lies within
a predicted POU2F1 binding site located close to a RARA binding
site identified by ChIP-chip, we hypothesized that this SNP
influences the transcriptional response to RA. Consistent with this
hypothesis, we showed that POU2F1 and RARA do bind to the
genomic region spanning and near SNP rs11868112, respectively.
Furthermore, reporter gene assays suggest that this region functions
as a RA-dependent enhancer and that the allele status at
rs11868112 affects enhancer activity. Although we cannot conclu-
sively identify the target gene of this enhancer, RPTOR appears to
be a strong candidate because it is induced by the selective RARA
agonist AM580 in two different cell lines. The fact that the time of
differential RPTOR expression in response to RA treatment
coincides with the time of allele-specific down-regulation in reporter
gene assays further supports this proposal. Overall, these results
provide an example of how a selection signal can identify a
functional SNP and suggest a role for the regulation of RPTOR
expression in human adaptations to different environments.
Despite the clear signal of selection given by the correlation
between allele frequency and climate variables, standard neutrality
tests did not detect a significant departure from expectations. This
included tests of the frequency spectrum as well as haplotype
homozygosity (as assessed by the extended haplotype homozygosity
[39] or integrated haplotype score statistics [40]). However, these
tests are powerful when selection acts on a new rather than an
existing mutation [30,31] and when selection acts on a dominant or
codominant allele [41]. In the case of SNP rs11868112, the
beneficial allele in cold climates segregates at appreciable
frequencies in sub-Saharan African populations (8%–43%), thus
suggesting that this variant predates the dispersal of human
populations out of Africa and that this allele was neutral before
becoming advantageous when humans moved to colder climates.
Modeling studies have shown that under these circumstances
standard neutrality tests have inadequate power to detect a signal of
selection. For example, simulations of a model of directional
selection on standing variation determined that, if a neutral allele
occurred at frequency greater than 5% prior to becoming
advantageous, virtually no signature is expected on the frequency
spectrum, on patterns of linkage disequilibrium and on polymor-
phism levels [31]. Given the relatively high frequency of the derived
allele at rs11868112 in sub-Saharan African populations, it is
therefore not surprising that we detected a signature of natural
selection only by using the climate correlation approach.
The molecular function of RPTOR is consistent with a role in
local adaptations. This is because the MTORC1 complex, which
contains RPTOR as a critical component, integrates environmen-
tal signals to regulate cell growth, metabolism and survival ([42]
and references therein). However, given the diversity of biological
processes regulated by MTORC1 and by retinoids, it is difficult to
pinpoint the function of RPTOR that is the most likely target of
selection. One possibility is that SNP rs11868112 influences the
regulation of energy metabolism and mitochondrial function;
under this model, the derived allele would have conferred a
selective advantage by increasing thermogenesis during the
dispersal to progressively colder climates. This scenario is
supported by the fact that the MTOR pathway controls
mitochondrial function, especially ATP synthetic capacity [43],
directly [44] and indirectly [45]. Tissue-specific knockouts (KOs)
of raptor have provided further support for the critical role of
mTORC1 signaling on whole body metabolism. Adipose-specific
raptor KO mice are resistant to diet-induced obesity, due to an
increased mitochondrial uncoupling in white adipose tissue
[46,47]. Because mitochondrial uncoupling is an important
mechanism for generating body heat, it is possible that the
selective advantage conferred by SNP rs11868112 is due to its
effect on thermogenesis and cold tolerance. Adaptations to cold
climates are evident in the geographic distributions of many traits.
For example, significant correlations exist between body mass and
temperature [10,48], consistent with the long standing hypotheses
that variation in body size and proportions are adaptations to
maintain temperature homeostasis [49,50]. Furthermore, there is
evidence that human metabolism has been shaped by adaptations
to cold stress from studies of arctic populations, which exhibit
elevated basal metabolic rates compared to non-indigenous
populations [11].
Figure 6. Reporter gene assays. In HepG2 (A) and MCF-7 (B) at different times after treatment with AM580. The relative luciferase activity is
determined by the ratio between AM580 and DMSO treatment. Data is expressed as mean 6 standard deviation. * P,0.05; ** P,0.01.
doi:10.1371/journal.pgen.1001178.g006
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wellestablished,thegeneticfactorscontributingtotheseadaptations
are only partially understood. Genetic variants that can increase
mitochondrial uncoupling efficiency might be advantageous in cold
climates and thus may have been selected during human migrations
northward. The derived T allele rs11868112, which is associated
with lower RA-dependent transcription levels, may result in
increased mitochondrial uncoupling in adipose tissue and, hence,
higher thermogenesis. Consistent with the hypothesis that this allele
confers resistance to cold stress, it increases in frequency with
decreasing winter temperatures in worldwide population samples,
and it is relatively rare in the equatorial populations of sub-Saharan
Africa and South East Asia (see Figure 2). Although a role for RA in
thetranscriptionalinductionofRPTORwasnotpreviouslyreported,
retinoids have been long known to regulate thermogenesis and
energy expenditure through their effects on the expression of the
major uncoupling protein gene, UCP1, in brown adipose tissue
(BAT) [51]. This protein plays a key role in nonshivering
thermogenesis, which is the main mechanism for heat generation
in human infants. As with the RPTOR gene, a distal enhancer
upstream to the proximal UCP1 promoter was found to contain a
RARresponseelement,whichmediates itstranscriptional induction
[36,52]. Therefore, our finding that the transcription of the RPTOR
gene is induced by RA treatment in liver and breast epithelial cells is
consistent with the known function of RAR in regulating the
expression of another gene with a clear role in thermogenesis. More
recently, experiments in mice identified a role for retinoids in
adipose tissue remodeling and, more specifically, in the acquisition
of BAT-like properties in white adipose tissue [53]. These findings
further support the notion that the biological functions of RAR
include the regulation of energy balance and thermogenesis.
Moreover, our observation that RPTOR is induced by retinoids
provides a possible mechanistic link connecting the action of
retinoids in adipose tissue remodeling and the finding that the
adipose-specific raptor KO exhibits increased mitochondrial uncou-
pling (i.e. a typical BAT property) in white adipose tissue.
Another possible explanation for the signal of selection observed
at SNP rs11868112 may be related to the role of the MTOR
pathway in the regulation of the immune response. Indeed, the
MTOR pathway plays multiple roles in immunity, especially in
the activation and proliferation of T cells [20], and has been
implicated in the etiology of autoimmune disorders, such as
systemic lupus erythematosus (SLE) [54]. Moreover, the specific
inhibitors for this pathway, rapamycin and its derivatives, can
decrease proliferation of T lymphocytes and are used as
immunosuppressant to avoid allograft rejection [20] or to treat
autoimmune patients [55,56]. Since pathogen diversity decreases
with latitude mainly as a result of climatic factors [57], the optimal
level of immune response is also expected to vary according to
latitude and climate. Therefore, we hypothesize that the increase
in the frequency of the derived T allele with decreasing
temperatures is due to selective pressures acting on the MTORC1
function in the regulation of the immune response. Under this
scenario, the decrease in RPTOR expression associated with the T
allele at high latitudes could reflect a shift to maintain the
appropriate balance between pathogen pressures and immune
response, with an exaggerated immune response possibly resulting
in increased risk for autoimmune diseases.
It might be argued that the modest (,20%) decrease of RPTOR
expression associated with the T allele is not sufficient to generate
significant phenotypic and fitness differences between arctic and
tropical populations. One possibility is that RPTOR and the
MTOR pathway are located at the top of the signaling cascade
[19], therefore, a subtle change in its expression can have major
consequences. Alternatively, as observed for most susceptibility
SNPs identified through GWAS of common diseases, rs11868112
may be just one of many SNPs with small effects on the
phenotypes that are adaptive in different climates.
Materials and Methods
Data mining
Genotype data in the RPTOR gene for HGDP individuals was
obtained from published Illumina HumanMap 650Y data (http://
hagsc.org/hgdp/files.html). The genotype data for the same SNPs
from four HapMap Phase III populations (Luhya, Maasai,
Tuscans, and Gujarati) (http://www.hapmap.org) and five
additional populations (Vasekela !Kung from South Africa,
lowland Amhara from Ethiopia, Naukan Yup’ik and Maritime
Chukchee from Siberia, and Australian Aborigines) were also
incorporated (Hancock and Di Rienzo, personal communication).
In total, 61 human populations were included in the current study.
This study uses the Bayesian geographic analyses method of Coop
et al. (2010) [27], which is a model-based method that tests
whether a linear relationship between allele frequency and a
variable provides a significantly better fit to the data than the null
model alone (where the null model is given by a matrix of the
covariance of allele frequencies between populations). The
environmental variables included latitude and seven climate
variables in the summer and winter seasons.
Re-sequencing and analysis
Twenty-four unrelated Hapmap samples (8 YRI, 8 CEU and 8
ASN) were chosen for re-sequencing the coding regions and 48
unrelated HapMap samples (16 YRI, 16 CEU, and 16 ASN) for
re-sequenced in the non-coding regions. cDNA was synthesized
from RNA extracted from the lymphoblastoid cell lines of the
HapMap samples using the Super Transcript III First-Strand
Synthesis System for RT-PCR (Invitrogen, Carlsbad, CA) and
utilized as template. Conserved non-coding regions were identified
by using the ECR genome browser (http://ecrbrowser.dcode.org/)
and by choosing regions conserved between human and at least
two additional species (see Figure S3). A 2.6 kb segment spanning
SNP rs11868112 as well as the RPTOR promoter were also
included in the resequencing survey. PCR was performed by
using the primers in Table S5. After exonuclease I and Shrimp
Alkaline Phosphatase (United States Biochemicals, Cleveland,
OH) treatment, sequencing was performed by using internal
primers in Table S5 and BigDye Terminator v3.1 (Applied
Biosystems, Foster City, CA). In total, 34.4 kb (6.0 kb for coding
and 28.4 kb for non-coding) were amplified and re-sequenced.
Polymorphisms were scored by PolyPhred [58] and confirmed
visually. Visual genotype and LD between SNPs were determined
by using the Genome Variation Server (http://gvs.gs.washington.
edu/GVS/). Population genetics indices, including segregating
sites (S), nucleotide diversity (p) [59], Watterson’s estimator of the
population mutation rate parameter (hw) [60], Tajima’s D [61],
were calculated by Slider (http://genapps.uchicago.edu/labweb/
index.html). The expected distribution of nucleotide diversity and
Tajima’s D was generated by coalescent simulations using the
software ms [62] with appropriate demographic models [63]. All
re-sequencing data will be made publicly available in PharmGKB
(http://www.pharmgkb.org).
Cell culture
The human hepatocellular carcinoma cell line HepG2 was
cultured in minimum essential medium (MEM, ATCC, Manassas,
VA) supplemented with 10% fetal bovine serum (FBS, Invitrogen,
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maintained in Dulbecco’s Modified Eagle’s Medium (DMEM;
Invitrogen) with 10% FBS and 0.1% insulin (Sigma, St. Louis,
MO). Before any AM580 or DMSO treatment, cells were grown
for 48 hrs in medium with 10% charcoal-stripped FBS
(Invitrogen).
Quantification of RPTOR mRNA expression
Cells were treated with 100 nM AM580 (Sigma) or DMSO
(Sigma) for 2hrs, 4hrs, 8hrs, 12hrs, 24hrs, and 48hrs, and then
harvested. RNA was extracted using the RNeasy Mini Kit
(Qiagen, Valencia, CA) and cDNAs were synthesized with the
High Capacity Reverse Transcription Kit (Applied Biosystems).
RPTOR mRNA levels were determined by real time PCR using
the power SYBR green (Applied Biosystems) with primers 59-
CGGGGAGGTCTGGGTCTTCAA-39 and 59-CTCCTGCTC-
CCGCTGTAGTGC-39 [64]. b-actin was used as a calibrator gene
in real time PCR with the primers 59-ACGTGGACATCCG-
CAAAGAC-39 and 59-CAAGAAAGGGTGTAACGCAACTA-
39 [65]. For each of three independent biological replicates, three
technical replicates were performed for each time point on a
StepOne Plus Realtime PCR System (Applied Biosystems).
ChIP-PCR
ChIP was carried out using the ChIP Assay Kit (Upstate,
Indianapolis, IN) according to the manufacturer’s protocol.
Briefly, 10
7 cells grown for 48 hours in medium with charcoal-
stripped FBS and then treated with 100nM AM580 or DMSO for
1 hr, were incubated for 10 minutes with 1% formaldehyde at
room temperature. The fixed cells were treated with 1.25 M
glycine for 5 minutes, washed twice with ice-cold phosphate
buffered saline (Invitrogen) containing protease inhibitor cocktail
(PIC, Sigma) and phenylmethylsulfonyl fluoride (PMSF, Fisher,
Pittsburgh, PA), scraped, lysed and sonicated to obtain 200–
800 bp fragments with the Sonicator 4000 (MISONIX, Farming-
dale, NY). The solubilized chromatin was diluted 10-fold with
dilution buffer, and pre-cleared with protein A beads. After
centrifuging and transferring the supernatant, 1% sample was
stored as input and the remaining chromatin was incubated with
rabbit polyclonal anti-POU2F1 (sc-232X) or anti-RARA (sc-
551X; Santa Cruz Biotechnology, Santa Cruz, CA) and normal
rabbit IgG (Santa Cruz Biotechnology) and immunoprecipitated
with protein A beads. After washing with low salt, high salt, LiCl
and TE buffer twice, the immunoprecipitated chromatin was
eluted and de-crosslinked. Upon proteinase K treatment (Qiagen)
DNA was recovered by QIAquick PCR purification kit (Qiagen).
The obtained DNA was quantified by real time PCR with iQ
SYBR green (Bio-Rad, Hercules, CA) and primer pairs 59-
AGGTCTGCAACACAGCACAT -39 and 59- CTGGGAGC-
TATGCCTGGTC -39, and 59-CTAAGTGCTGGGTCGTA-
AGTTGT-39 and 59-GAATGCAGGCTATAAATCAGGAG-39
to quantify the enrichment for POU2F1 and RARA binding site,
respectively. For each ChIP assay, three technical replicates were
performed for three biological replicates on a StepOne Plus
Realtime PCR System (Applied Biosystems).
Luciferase reporter gene assays
A 3.7 kb segment containing the derived T allele of rs11868112
and the putative RAR binding site (see Figure S4) was amplified by
nested PCR. In the first round of PCR the primers 59-
TTGCGAAAGTAAATGCTAT-39 and 59-CAGAGGGGCC-
TTGAGATGACCA-39 were used. In the second round of PCR
the primers 59-CAGTC-GCTAGC-TTCCCTCACTCTGTCC-
CCCAATG-39 and 59-CAGTC-CTCGAG-TTCCTGACCTG-
CCAAATCTGTG-39 were used to append the PCR fragment
with NheI and XhoI restriction sites, respectively. For both PCR
reactions, iProof High-Fidelity DNA Polymerase (Bio-Rad) was
used to avoid the introduction of mutations. After digestion with
NheI and XhoI (New England Biolabs, Ipswich, MA), the DNA
fragment was cloned into the pGL3-promoter vector (Promega,
Hercules, CA). The plasmid with the ancestral allele (C) was
generated with the QuikChange Site-Directed Mutagenesis Kit
(Stratagene, La Jolla, CA) using primer pair 59-GCCCTTGA-
CAAGCTCACAAACTTGTAGGAGGG-39 and 59-CCCTC-
CTACAAGTTTGTGAGCTTGTCAAGGGC-39 (target in bold)
according to the manufacturer’s recommendations. All plasmids
were verified by sequencing prior to following experiments.
Two million HepG2 cells or 2.5*10
6 MCF-7 cells were seeded
into 10-cm plates 24 hours before transfection. Plasmid DNA
(9.5 mg) was transfected using FuGene HD (Roche, Indianapolis,
IN) according to the manufacturer’s recommendations. Plasmid
pRL-TK (Promega) DNA (0.5 mg) was co-transfected as internal
control. Twenty-four hours after transfection, cells were split,
cultured for 12h, and starved for 48 hours in medium with
charcoal-stripped FBS. After treatment with 100nM AM580 or
DMSO for 2hrs, 4hrs, 8hrs, 12hrs, 24hrs, and 48hrs, cells were
harvested and luciferase activity was determined using the Dual-
Luciferase Reporter Assay System (Promega) according to the
manufacturer’s protocol. The enhancer activity was determined as
the ratio between Firefly and Renilla luciferase activity. Four
independent replicates were performed for each experiment.
Statistical analyses
For all analyses of expression, POU2F1 and RARA binding,
and reporter gene data, we used independent two-tailed t-tests in
SPSS 15.0 (SPSS Inc., Chicago, IL) and the null hypothesis was
rejected when P,0.05.
Supporting Information
Figure S1 Visual genotype for RPTOR coding region resequen-
cing. Each column indicates one SNP while each array denotes
one individual. Blue, red, and yellow represent homozygous of
common allele, heterozygous, and homozygous of rare allele,
respectively. Af, Eu, and As indicate YRI, CEU, and ASN
HapMap populations, respectively. All positions refer to RPTOR
mRNA sequence (Genbank ID NM_020761).
Found at: doi:10.1371/journal.pgen.1001178.s001 (0.05 MB TIF)
Figure S2 Visual genotype for RPTOR non-coding region
resequencing. Each column indicates one SNP while each array
denotes one individual. Blue, red, yellow, and grey represent
homozygous of common allele, heterozygous, homozygous of rare
allele, and missing data, respectively. Af, Eu, and As indicate YRI,
CEU, and ASN HapMap populations, respectively. All positions
refer to the genome sequence (build 36) for chromosome 17.
Found at: doi:10.1371/journal.pgen.1001178.s002 (2.18 MB
TIF)
Figure S3 Seleted region for RPTOR non-coding resequencing
in this study. The human RPTOR gene cluster is aligned to frog,
fish, chicken, opossum, mouse, dog, and macaque (from top to
bottom) genomes by ECR browser (http://ecrbrowser.dcode.org/
). The vertical bar on top represents surveyed regions while red,
blue, and green indicate conserved non-coding region, promoter,
and rs11868112 nearby region, respectively. The sequence
identity ranges from 50% to 100% and is displayed by the height
of the peak while green, blue, salmon, red, and yellow denote
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respectively.
Found at: doi:10.1371/journal.pgen.1001178.s003 (0.13 MB TIF)
Figure S4 Schematic figure for the enhancer ,25kb upstream
of RPTOR. The black bars from left to right indicate POU2F1,
RAR binding sites and RPTOR gene, respectively. The distances
between them are displayed below. The primer position for ChIP-
real time PCR, the SNP in predicted POU2F1 binding site is also
provided.
Found at: doi:10.1371/journal.pgen.1001178.s004 (0.03 MB
TIF)
Table S1 Derived allele frequencies of the RPTOR SNPs in the
different human populations.
Found at: doi:10.1371/journal.pgen.1001178.s005 (0.15 MB
XLS)
Table S2 Bayes Factors for the RPTOR SNPs in the HGDP
panel.
Found at: doi:10.1371/journal.pgen.1001178.s006 (0.55 MB
DOC)
Table S3 Bayes Factors empirical p values for the RPTOR SNPs
in the HGDP panel.
Found at: doi:10.1371/journal.pgen.1001178.s007 (0.55 MB
DOC)
Table S4 Population index for the resequenced regions in YRI
(A), CEU (B), and the ASN (C) populations.
Found at: doi:10.1371/journal.pgen.1001178.s008 (0.08 MB
DOC)
Table S5 Primers for RPTOR PCR and resequencing in this
study.
Found at: doi:10.1371/journal.pgen.1001178.s009 (0.05 MB
DOC)
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